Dia/Fda Oligonucleotide-Based Therapeutics Conference 2024. The ots offers scholarships, awards and travel grants annually. Biologists, residents, chemists, researchers, cell biologists, medicinal chemists, molecular biologists, biomedical engineers/technologists, clinical pharmacologists


Dia/Fda Oligonucleotide-Based Therapeutics Conference 2024

Register early bird rates expire in days. Register early bird rates expire in days.

Developed Collaboratively By Regulators, Industry Professionals, And Academics, The Program Covers A Wide Range Of Topics From The Nonclinical, Cmc, And.

Hot topics in oligonucleotide therapeutics;

Register Early Bird Rates Expire In Days.

Biologists, residents, chemists, researchers, cell biologists, medicinal chemists, molecular biologists, biomedical engineers/technologists, clinical pharmacologists

Register Early Bird Rates Expire In Days.

Images References :

Register Early Bird Rates Expire In Days.

This event brings together leading experts from industry and regulatory bodies to inform, educate and share advancements in oligonucleotide based therapeutic product development.

Emerging Technologies And Therapeutic Approaches Two Keynote Sessions:

The 2019 event will address quality risk management, manufacturing advances, specifications, formulation issues, cmc strategies, oligonucleotide pharmacokinetics, nonclinical assessments in.

The Annual Meeting Is Open To Anyone Interested Or Involved In Oligonucleotide Therapeutics.